Canine bone marrow study spotlights processing effects on IHC

CURRENT FULL VERSION: A new line of canine bone marrow research is sharpening attention on a deceptively basic part of diagnostics: tissue processing. The latest study highlighted here examines how fixation and demineralization affect immunohistochemical assessment of canine bone marrow, a question that matters because marrow cores often have to do double or triple duty for routine histology, immunophenotyping, and sometimes molecular follow-up. While the full immunohistochemistry paper was not readily accessible in the sources returned, closely related peer-reviewed work from the same author group provides strong context for what’s at stake. (pmc.ncbi.nlm.nih.gov)

That background study, published in Veterinary Pathology in 2024, evaluated 73 canine sternal marrow samples collected within 24 hours of death. The investigators compared two fixatives, acetic acid-zinc-formalin and 10% neutral-buffered formalin, and three demineralization methods, hydrochloric acid, formic acid, and EDTA. They found no significant morphology advantage for acetic acid-zinc-formalin over neutral-buffered formalin, but they did find a clear demineralization effect: EDTA outperformed both acids for histomorphology, and formic acid outperformed hydrochloric acid. (pmc.ncbi.nlm.nih.gov)

The molecular findings were even more striking. DNA amplification succeeded in 29 of 36 EDTA-demineralized samples, versus just 2 of 72 samples treated with either acid. The authors concluded that EDTA, though more labor-intensive and slower than acid-based methods, was critical for PCR amplification with their extraction approach and yielded superior morphology overall. In the discussion, they also noted that the effects of acetic acid-zinc-formalin versus neutral-buffered formalin on immunohistochemistry still needed to be determined, which appears to be the gap the immunohistochemistry-focused paper is addressing. (pmc.ncbi.nlm.nih.gov)

That preservation issue also fits with findings outside marrow pathology. In an Animals study on DNA recovery from deer antlers and prepared trophy skulls, researchers developed a simple, low-cost organic solvent protocol that used bead-based mechanical homogenization, a 4-hour enzymatic digestion in EDTA buffer with N-lauryl sarcosine and Proteinase K, followed by phenol-chloroform-isoamyl alcohol purification and centrifugal filtration. Tested on 60 samples—30 antlers and 30 pedicle portions from roe deer, fallow deer, and red deer—the method produced DNA of sufficient quality for downstream analysis, and multiplex PCR of species-specific microsatellite markers generated complete genotypes from all 60 samples. Although that was a different specimen type and use case, it adds a practical example of the same broader point: EDTA-based processing can help preserve molecular utility in mineralized tissues, even when starting material is limited or heavily processed.

That fits with the wider pathology literature. The International Council for Standardization in Haematology’s guidelines for bone marrow immunohistochemistry describe biopsy evaluation as integral to marrow investigation and position immunohistochemistry as a common ancillary test. Broader human pathology data also show that decalcification protocol can alter immunohistochemical and molecular readouts in bone-containing samples, with EDTA generally preserving assay performance better than stronger acid approaches. The Hammersmith bone marrow trephine protocol, a long-cited reference in marrow pathology, likewise describes EDTA-based processing as part of an optimized workflow. (icsh.org)

There doesn’t appear to be a separate institutional press release or broad industry reaction tied to this canine marrow paper in the web results, but the direction of the findings is consistent with expert guidance and with concerns already familiar to diagnostic pathologists: pre-analytic handling can shape what stains and assays can reliably show. That’s especially relevant in veterinary medicine, where marrow biopsies are technically demanding to collect and often limited in size, making repeat sampling difficult for the patient and the clinical team. This is an inference from the available evidence rather than a direct quote from outside commentators. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, the message isn’t just technical, it’s operational. If a marrow sample might need IHC, PARR, or other molecular testing, the lab’s default decalcification choice may influence whether that sample remains fully usable. Faster acid-based workflows may help turnaround time, but they can come at the cost of antigen preservation and nucleic acid quality. In suspected lymphoma, leukemia, myelodysplastic syndromes, metastatic disease, or marrow-targeting infections, that tradeoff could affect diagnostic confidence and, ultimately, case management. The deer antler study is not a marrow study, but it reinforces the same practical principle for hard tissues: with the right EDTA-based workflow, even processed mineralized specimens can remain informative for genotyping and other molecular applications. (pmc.ncbi.nlm.nih.gov)

A second implication is standardization. The 2024 paper explicitly notes that fixation and demineralization protocols for bone marrow are not standardized across diagnostic laboratories. For practices sending samples to outside labs, that means pre-submission communication may matter more than many clinicians realize, particularly when ancillary testing is likely. For labs, it raises the question of whether one-size-fits-all marrow processing is still defensible as testing menus expand. The success of a relatively simple EDTA-based extraction workflow in another mineralized-tissue setting also underscores that preserving downstream molecular options does not always require highly specialized or kit-dependent methods. (pmc.ncbi.nlm.nih.gov)

What to watch: The next step is whether the immunohistochemistry-specific study identifies marker-by-marker vulnerabilities and produces protocol recommendations that labs can implement without unacceptable delays. If those data clearly favor EDTA for diagnostically important canine marrow antibodies, expect more discussion around split-sample workflows, reflex testing pathways, and updated submission guidance for marrow biopsies. More broadly, watch whether veterinary diagnostic labs begin to align marrow and other mineralized-tissue workflows more explicitly around molecular preservation, not just histology turnaround. (icsh.org)